Abstract
Patients with persistent cytopenia are frequently referred to the haematological departments , and a diagnosis of myelodysplastic syndrome is often suspected. After routine assessment including a broad range of blood tests, bone marrow biopsy, and cytogenetics, a definite diagnosis can still not be found for some patients, although they have symptomatic cytopenia. In these cases, next generation sequencing is a valuable supplement in identifying patients with early stages of myeloid cancer.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 179 |
Udgave nummer | 25 |
Sider (fra-til) | V03170179 |
ISSN | 0041-5782 |
Status | Udgivet - 19 jun. 2017 |